New Market Research Report: Xalkori (Non-Small Cell Lung Cancer) – Forecast … – SBWire (press release)

by lowes1 on October 1, 2013

New Market Research Report: Xalkori (Non-Small Cell Lung Cancer) – Forecast
SBWire (press release)
Boston, MA — (SBWIRE) — 10/01/2013 — Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However 
Oncolytics Biotech Inc. Collaborators to Present Positive Clinical Trial Data MarketWatch
Interim Data for Merck's MK-3475, an Investigational Anti-PD-1 Immunotherapy Wall Street Journal

all 3 news articles »

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: